crta
Hrvatska znanstvena Sekcija img
bibliografija
3 gif
 Naslovna
 O projektu
 FAQ
 Kontakt
4 gif
Pregledavanje radova
Jednostavno pretraživanje
Napredno pretraživanje
Skupni podaci
Upis novih radova
Upute
Ispravci prijavljenih radova
Ostale bibliografije
Slični projekti
 Bibliografske baze podataka

Pregled bibliografske jedinice broj: 213685

Zbornik radova

Autori: Cebalo, Ljiljana; Martinković, Franjo; Marinculić, Albert; Markotić, Alemka
Naslov: Aktivnost azitromicina tijekom infekcije humanih monocita/makrofaga s leishmanijom infantum
( Activity of azithromycin during leishmania infantum infection of human monocytes/macrophages )
Izvornik:
Skup: Godišnji sastanak Hrvatskog Imunološkog društva 2005
Mjesto i datum: Božava, Hrvatska, 29.09 - 02.10. 2005.
Ključne riječi: leishmanija infantum; azithromycin
( leishmania infantum; azithromycin )
Sažetak:
Visceral leishmaniasis (VL) is a chronic infectious disease caused by parasites of the genus Leishmania. Some success was achieved in the threatment of VL, but side effects and drug resistance are still serious problems. Leishmanias in humans live in macrophages as intracellular amastigotes, while in their sandfly vector live as extracellular promastigotes. As azithromycin (azalide antibiotic) concentrates in the tissues, especially in the macrophages we proposed that it could have a possible antileshmanial activity. The aim of this study was to investigate the activity of azithromycin against Leishmania infantum in infection of human monocytes. In addition, we wanted to detect possible immunomodulatory effects of tested drugs. For that purpose we isolated human monocytes from peripheral blood and infected them with logarithmic phase L. infantum promastigotes. Uninfected cells were used as controls. After incubation (24 hours) we added azithromycin or amphotericin B in different concentrations and after 3 days assessed the number of infected cells (per 100 cells), the number of amastigotes (per 100 cells) and the number of amastigotes per infected cell. We also did some proteinarray testing (Human Antibody Array III and 3.1, RayBiotech, Inc., USA) including 42 different inflammatory proteins from collected culture supernatants. We did not find any difference in the number of leishmania infected cells or in the number of amastigotes between azithromycin treated and control cells. In supernatants of uninfected monocytes azithromycin increased the level of IL-6 and decreased the levels of MIP-1β and TIMP-2, while amphotericin B decreased the levels of MIP-1β and TIMP-2. When monocytes infected with leishmania promastogotes were treated with azithromycin we found a decrease in the levels of MCP-1, TIMP-2 and MIP-1β , while amphotericin B treatment of Leishmania promastigotes influenced the production of IL-6 and decreased the production of MCP-1 and TIMP-2. Our results show that L. infantum is not susceptible to azithromycin treatment. However, there are some differences in immunomodulatory effects between azithromycin and amphotericin B. Further analyzes are necessary to find out which mechanisms are behind drug-resistance in leishmania infections.
Vrsta sudjelovanja: Poster
Vrsta prezentacije u zborniku: Sažetak
Vrsta recenzije: Domaća recenzija
Projekt / tema: 0021005
Izvorni jezik: eng
Kategorija: Znanstveni
Znanstvena područja:
Temeljne medicinske znanosti



Verzija za printanje   za tiskati


upomoc
foot_4